Garelli, S.
Dalla Costa, M.
Sabbadin, C.
Barollo, S.
Rubin, B.
Scarpa, R.
Masiero, S.
Fierabracci, A.
Bizzarri, C.
Crinò, A.
Cappa, M.
Valenzise, M.
Meloni, A.
De Bellis, A. M.
Giordano, C.
Presotto, F.
Perniola, R.
Capalbo, D.
Salerno, M. C.
Stigliano, A.
Radetti, G.
Camozzi, V.
Greggio, N. A.
Bogazzi, F.
Chiodini, I.
Pagotto, U.
Black, S. K.
Chen, S.
Rees Smith, B.
Furmaniak, J.
Weber, G.
Pigliaru, F.
De Sanctis, L.
Scaroni, C.
Betterle, C.
Funding for this research was provided by:
EU (2006-005223, 2008-201167)
Università degli Studi di Padova
Article History
Received: 8 March 2021
Accepted: 29 April 2021
First Online: 18 May 2021
Declarations
:
: SC, BRS, JF, and SKB are employees of RSR Ltd. RSR Ltd is a developer of medical diagnostics including assays and/or kits for measuring 21-OH Abs, 17α-hydroxylase Abs, side-chain cleavage enzyme Abs, tryptophan hydroxylase Abs, interferon-ω Abs, aromatic-<scp>l</scp>-aminoacid-decarboxylase Abs, and TSH-Receptor Abs.
: This study does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.